Lysosomal-associated transmembrane protein 5 deficiency exacerbates cerebral ischemia/reperfusion injury

Overview of attention for article published in Frontiers in Molecular Neuroscience, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

The function and mechanism of LAPTM5 in diseases

Article in Biomedicine & Pharmacotherapy (August 2024)

Bioinformatic analyses reveal lysosomal-associated protein transmembrane 5 as a potential therapeutic target in lipotoxicity-induced injury in diabetic kidney disease

Article in Renal Failure (June 2024)

Research progress on immune-related therapeutic targets of brain injury caused by cerebral ischemia

Article in Cytokine (May 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.